Episode notes
This week, we have conversations with Jakob Andersson, vice president of engineering at Anaphora and founder and chairman of GAIA; Coave Therapeutics’ CEO Rodolphe Clerval; and MOBILion Systems’ CEO, Melissa Sherman.
Times:
03:13 Coave Therapeutics
24:43 GAIA Conference
36:55 MOBILion Systems
Genetic medicine for ophthalmology
Coave Therapeutics is a Paris‑based biotechnology company focused on developing genetic medicines using its ALIGATER platform. The company has pioneered ligand‑conjugated AAV vectors, enabling precision capsids that are highly tissue‑specific, safer, and more effective.
In October 2025, Coave presented data at the European Society of Gene ...
Keywords
biotechbiotechnologyartificial intelligenceophthalmologySwedenMOBILion SystemsCoave TherapeuticsGAIAAnaphora